Liabilities / Assets
88th percentile
Higher debt load relative to assets than 88% of similar nonprofits.
990 • Fiscal year 2017 • EIN 20-2710571
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
88th percentile
Higher debt load relative to assets than 88% of similar nonprofits.
Liabilities / Revenue
84th percentile
Higher debt load relative to revenue than 84% of similar nonprofits.
Net Margin
80th percentile
Higher net margin than 80% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
100th percentile
Faster asset growth than 100% of similar nonprofits.
Revenue Growth
Score unavailable
A valid growth rate could not be computed from the available filing history.
Assets
Up$598,089
Up $598,088 (+59808800%) from 2016
Net Assets
$198,458
No earlier filing loaded for comparison.
Liabilities
Up$399,631
Up $399,631 from 2016
Revenue
Up$829,303
Up $829,303 from 2016
Expenses
Up$630,845
Up $630,845 from 2016
Net Income
Up$198,458
Up $198,458 from 2016
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The mission of the organization is to accelerate the discovery and development of applications of new therapies for disease and translate those therapies into treatments for patients through the science of regenerative medicine. The organization focuses on obtaining federal and other grant funds and working with other organizations developing regenerative medicine and products to accomplish its mission.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.